Clinical Trials Logo

Clinical Trial Summary

This is a study to investigate the efficacy and safety of epirubicin, cisplatin and capecitabine (ECX) as neoadjuvant therapy prior to radical chemoradiotherapy using capecitabine and cisplatin as radio-sensitisers in patients with newly diagnosed localized squamous cell carcinoma of the oesophagus.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00220129
Study type Interventional
Source Royal Marsden NHS Foundation Trust
Contact
Status Completed
Phase Phase 2
Start date November 2002

See also
  Status Clinical Trial Phase
Completed NCT04027543 - Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study)
Recruiting NCT05714553 - NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours Phase 1/Phase 2
Active, not recruiting NCT03835663 - The Bacterial Composition of the Stomach in Reflux Disease
Active, not recruiting NCT03246516 - Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers N/A
Terminated NCT02999893 - A Study of APR-246 in Oesophageal Cancer Phase 1/Phase 2